Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports-March 2024-www.financetom.com

Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Jun 16, 2025 4:51 PM

June 16 (Reuters) - Eli Lilly ( LLY ) is in advanced

talks to acquire gene editing startup Verve Therapeutics ( VERV )

for up to $1.3 billion, the Financial Times reported on

Monday, citing people familiar with the matter.

Reuters could not immediately verify the report.

Previous page： Pfizer’s $43 billion purchase of Seagen gets green light from EU antitrust Next page： Pakistan's national carrier resorts to flight cancellation owing to non-payment of dues

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Pfizer’s $43 billion purchase of Seagen gets green light from EU antitrust

Oct 20, 2023

Pfizer announced the deal in March, its largest purchase in a string of recent acquisitions thanks to a once-in-a-lifetime cash windfall from its COVID-19 vaccine and treatment.

Pakistan's national carrier resorts to flight cancellation owing to non-payment of dues

Oct 23, 2023

The airline, which was once considered the pride of Pakistan and was the first international airline to be given access to fly to Beijing, is said to be suffering millions in losses on a daily basis.

The US sanctions 10 Hamas members and its financial network over the surprise Israel attack

Oct 18, 2023

The sanctions are financial penalties meant to block access to funds held in the U.S. and to prevent the people and entities from doing business with American people and firms.

Mahindra, Volvo among corporations pushing for fossil fuel exit at COP28

Oct 23, 2023

Companies are increasingly committing to their own timelines for reducing their emissions, but many acknowledge that their ability to slow planet-warming CO2 emissions is contingent on faster action from governments.